Recombinant hirudin as an alternative for anticoagulation during cardiopulmonary bypass in patients with heparin-induced thrombocytopenia type II: A 1-year experience in 57 patients
- 1 June 2000
- journal article
- Published by Elsevier in Journal of Cardiothoracic and Vascular Anesthesia
- Vol. 14 (3) , 243-248
- https://doi.org/10.1016/s1053-0770(00)90117-4
Abstract
No abstract availableKeywords
This publication has 14 references indexed in Scilit:
- Recombinant Hirudin (Lepirudin) Provides Safe and Effective Anticoagulation in Patients With Heparin-Induced ThrombocytopeniaCirculation, 1999
- Heparin-associated Thrombocytopenia and ThrombosisAnesthesiology, 1997
- Rekombinantes Hirudin als Antikoagulans für den kardiopulmonalen Bypass in der Herzchirurgie: Klinische ErfahrungenZeitschrift für Herz-,Thorax- und Gefäßchirurgie, 1997
- High-volume, Zero-balanced Hemofiltration to Reduce Delayed Inflammatory Response to Cardiopulmonary Bypass in ChildrenAnesthesiology, 1996
- Cross-reactivity study of low molecular weight heparins and heparinoid in heparin-induced thrombocytopeniaThrombosis Research, 1996
- Prothrombin conversion intermediate effectively neutralizes toxic levels of hirudinThrombosis Research, 1995
- Heparin-Induced Thrombocytopenia in Patients Treated with Low-Molecular-Weight Heparin or Unfractionated HeparinNew England Journal of Medicine, 1995
- Heparinless cardiopulmonary bypass with ancrodThe Annals of Thoracic Surgery, 1994
- Pharmacology of r-hirudin in renal impairmentThrombosis Research, 1992
- Heparin-associated ThrombocytopeniaAnesthesiology, 1988